| 1 |
34078222 | A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene. | 2021 Jun 24 |
2 |
| 2 |
34329999 | Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitors. | 2021 Nov 15 |
2 |
| 3 |
31240161 | A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets. | 2019 May |
4 |
| 4 |
30240563 | Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter. | 2018 Oct 25 |
2 |
| 5 |
30266839 | Modelling brain dopamine-serotonin vesicular transport disease in Caenorhabditis elegans. | 2018 Nov 9 |
2 |
| 6 |
24321511 | N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux. | 2014 Feb 14 |
2 |
| 7 |
23363473 | Brain dopamine-serotonin vesicular transport disease and its treatment. | 2013 Feb 7 |
1 |
| 8 |
24018103 | Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia. | 2013 Nov |
2 |
| 9 |
22615537 | Relative nutritional deficiencies associated with centrally acting monoamines. | 2012 |
1 |
| 10 |
20818612 | Genetic models of serotonin (5-HT) depletion: what do they tell us about the developmental role of 5-HT? | 2011 Oct |
1 |
| 11 |
21365590 | [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder]. | 2011 Mar 1 |
2 |
| 12 |
17766642 | Identification of the substrate binding region of vesicular monoamine transporter-2 (VMAT-2) using iodoaminoflisopolol as a novel photoprobe. | 2007 Dec |
2 |
| 13 |
17876988 | [Development of newer antidepressant]. | 2007 Sep |
1 |
| 14 |
15695071 | Decreased platelet vesicular monoamine transporter density in habitual smokers. | 2005 Mar |
1 |
| 15 |
20641662 | (+)-2-Hydroxy-3-isobutyl-9-(3-[18F]fluoropropoxy)-10-methoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine | 2004 |
1 |
| 16 |
20641794 | 2-Hydroxy-3-isobutyl-9-[11C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11bH-bezo[α]-quinolizine | 2004 |
1 |
| 17 |
22319800 | 111In-Diethylenetriamine pentaacetic acid-IC2 rat monoclonal autoantibody to pancreatic β-cell surface antigen | 2004 |
1 |
| 18 |
22624173 | 125I-Single-chain antibody B5 targeting a pancreatic β-cell surface antigen | 2004 |
1 |
| 19 |
22624175 | 125I-Single-chain antibody B1 targeting a pancreatic β-cell surface antigen | 2004 |
1 |
| 20 |
14612158 | Impact of psychostimulants on vesicular monoamine transporter function. | 2003 Oct 31 |
2 |
| 21 |
11443533 | Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene. | 2001 Jul |
4 |
| 22 |
11669473 | Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter. | 2001 Sep 28 |
1 |
| 23 |
10473967 | Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. | 1999 Sep-Oct |
1 |
| 24 |
9461580 | Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. | 1998 Feb 13 |
2 |
| 25 |
9195934 | Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2. | 1997 Jun 27 |
3 |
| 26 |
8621690 | Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. | 1996 Feb 9 |
2 |
| 27 |
8606801 | Transport of histamine by vesicular monoamine transporter-2. | 1995 Nov |
1 |
| 28 |
8825897 | Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders. | 1995 Dec 18 |
1 |
| 29 |
7912402 | Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. | 1994 Mar |
1 |